Literature DB >> 18171628

Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study.

T Y Tang1, S P S Howarth, S R Miller, M J Graves, J M U-King-Im, Z Y Li, S R Walsh, P D Hayes, K Varty, J H Gillard.   

Abstract

INTRODUCTION: Inflammation is a recognized risk factor for the vulnerable atherosclerotic plaque. The aim of this study was to explore whether there is a difference in the degree of Magnetic Resonance (MR) defined inflammation using Ultra Small Super-Paramagnetic Iron Oxide (USPIO) particles, within carotid atheroma in completely asymptomatic individuals and the asymptomatic carotid stenosis in a cohort of patients undergoing coronary artery bypass grafting (CABG).
METHODS: 10 patients awaiting CABG with asymptomatic carotid disease and 10 completely asymptomatic individuals with no documented coronary artery disease underwent multi-sequence MR imaging before and 36 hours post USPIO infusion. Images were manually segmented into quadrants and signal change in each quadrant, normalised to adjacent muscle signal, was calculated following USPIO administration.
RESULTS: The mean percentage of quadrants showing signal loss was 94% in the CABG group, compared to 24% in the completely asymptomatic individuals (p<0.001). The carotid plaques from the CABG patients showed a significant mean signal intensity decrease of 16.4% after USPIO infusion (95% CI 10.6% to 22.2%; p<0.001). The truly asymptomatic plaques showed a mean signal intensity increase (i.e. enhancement) after USPIO infusion of 8.4% (95% CI 2.6% to 14.2%; p=0.007). The mean signal difference between the two groups was 24.9% (95% CI 16.7% to 33.0%; p<0.001).
CONCLUSIONS: These findings are consistent with the hypothesis that inflammatory atheroma is a systemic disease. The carotid territory is more likely to take up USPIO if another vascular territory is symptomatic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171628     DOI: 10.1016/j.ejvs.2007.10.019

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  17 in total

1.  High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Authors:  Fabien Hyafil; Andreas Schindler; Dominik Sepp; Tilman Obenhuber; Anna Bayer-Karpinska; Tobias Boeckh-Behrens; Sabine Höhn; Marcus Hacker; Stephan G Nekolla; Axel Rominger; Martin Dichgans; Markus Schwaiger; Tobias Saam; Holger Poppert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-03       Impact factor: 9.236

Review 2.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

Review 3.  Imaging biomarkers of cardiovascular disease.

Authors:  Jinnan Wang; Niranjan Balu; Gador Canton; Chun Yuan
Journal:  J Magn Reson Imaging       Date:  2010-09       Impact factor: 4.813

Review 4.  Clinical imaging of cardiovascular inflammation.

Authors:  Claudia Calcagno; Zahi A Fayad
Journal:  Q J Nucl Med Mol Imaging       Date:  2020-02-18       Impact factor: 2.346

5.  Intraplaque and Cellular Distribution of Dextran-Coated Iron Oxide Fluorescently Labeled Nanoparticles: Insights Into Atherothrombosis and Plaque Rupture.

Authors:  Claudia Calcagno; Zahi A Fayad
Journal:  Circ Cardiovasc Imaging       Date:  2017-05       Impact factor: 7.792

Review 6.  Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.

Authors:  Alexander Neuwelt; Navneet Sidhu; Chien-An A Hu; Gary Mlady; Steven C Eberhardt; Laurel O Sillerud
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

Review 7.  Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI part III.

Authors:  Bernard C M te Boekhorst; Maarten-Jan M Cramer; Gerard Pasterkamp; Cees J A van Echteld; Pieter A F M Doevendans
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-08       Impact factor: 2.357

8.  Molecular imaging of atherosclerosis: clinical state-of-the-art.

Authors:  Farouc A Jaffer; Johan W Verjans
Journal:  Heart       Date:  2013-12-23       Impact factor: 5.994

Review 9.  Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3).

Authors:  Zahi A Fayad; Filip K Swirski; Claudia Calcagno; Clinton S Robbins; Willem Mulder; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

10.  Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaques.

Authors:  T Y Tang; A J Patterson; S R Miller; M J Graves; S P S Howarth; J M U-King-Im; Z Y Li; U Sadat; V E Young; S R Walsh; J R Boyle; M E Gaunt; J H Gillard
Journal:  Neuroradiology       Date:  2009-03-20       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.